GC
TRIL

Gratus Capital’s Trillium Therapeutics Inc. TRIL Stock Holding History

Gratus Capital’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40,000
Closed -$162K – 174
2020
Q1 		$162K Buy
+40,000
New +$162K 0.03% 151